A randomized, double-blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV-positive patients. Commentary

Journal article

Peer reviewed

N DE WET, A LLANOS-CUENTAS, J Suleiman, E Baraldi, E. F Krantz, M DELLA NEGRA, H DIEKMANN-BERNDT and Rabih O Darouiche

Clinical infectious diseases, Vol.39(6), pp.842-852

2004

Abstract

Antibiotics. Antiinfectious agents. Antiparasitic agents

Antifungal agents

Biological and medical sciences

Human viral diseases

Infectious diseases

Medical sciences

Pharmacology. Drug treatments

Viral diseases

Viral diseases of the lymphoid tissue and the blood. Aids

1 Record Views

Title: A randomized, double-blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV-positive patients. Commentary
Creators - without role: N DE WET - Prime Cure Clinic, Durban, South Africa
A LLANOS-CUENTAS - Universidad Peruana Cayetano Heredia
J Suleiman - Instituto de Infectologia Emílio Ribas
E Baraldi - Embassy Drive Medical Center, Pretoria, South Africa
E. F Krantz - College Station Medical Center
M DELLA NEGRA - Instituto de Infectologia Emílio Ribas
H DIEKMANN-BERNDT - Fujisawa GmbH, Munich, Germany
Rabih O Darouiche - Baylor College of Medicine
Publication Details: Clinical infectious diseases, Vol.39(6), pp.842-852
Publisher: University of Chicago Press
Identifiers: 9919964308331
Academic Unit: King Faisal University
Language: English
Resource Type: Journal article